TristramDBahnsonMD
Cardiology • Durham, NCCardiac Electrophysiology, Interventional Cardiology, Non-Invasive Cardiology
Professor, Medicine, Duke University School of Medicine
Dr. Bahnson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
40 Duke Medicine Circle
Clinic 2F/2G
Durham, NC 27710Phone+1 919-681-5816
Summary
- Dr. Tristram Bahnson is a cardiologist and cardiac electrophysiologist in Durham, NC and is affiliated with Duke University Hospital. He received his medical degree from University of California San Francisco School of Medicine and has been in practice 33 years. He specializes in cardiac electrophysiology with an emphasis on catheter ablation for atrial fibrillation and complex arrhythmias including supraventricular and ventricular tachycardia.
Education & Training
University of California (San Diego) Medical CenterFellowship, Clinical Cardiac Electrophysiology, 1991 - 1992- University of California (San Diego) Medical CenterFellowship, Cardiovascular Disease, 1989 - 1992
Clinical Center at the National Institutes of HealthFellowship, Cardiovascular Disease, 1988 - 1989
University of California Davis HealthResidency, Internal Medicine, 1984 - 1986
University of California San Francisco School of MedicineClass of 1984
Certifications & Licensure
CA State Medical License 1985 - Present
NC State Medical License 1997 - 2025
MD State Medical License 1987 - 1990- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Clinical Cardiac Electrophysiology
- Heart Rhythm SocietyFellow (FHRS)
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial Start of enrollment: 2009 Nov 13
Publications & Presentations
PubMed
- 206 citationsAblation Versus Drug Therapy for Atrial Fibrillation in Heart Failure: Results From the CABANA Trial.Douglas L. Packer, Jonathan P. Piccini, Kristi H. Monahan, Hussein R. Al-Khalidi, Adam P. Silverstein
Circulation. 2021-04-06 - 863 citationsEffect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Rando...Douglas L. Packer, Daniel B. Mark, Richard A. Robb, Kristi H. Monahan, Tristram D. Bahnson
JAMA. 2019-04-02 - 121 citationsRecurrence of Atrial Fibrillation After Catheter Ablation or Antiarrhythmic Drug Therapy in the CABANA TrialJeanne E. Poole, Tristram D. Bahnson, Kristi H. Monahan, George Johnson, Hoss Rostami
Journal of the American College of Cardiology. 2020-06-30
Grant Support
- Receptor-Mediated Calcium Entry In Acinar CellsNational Heart, Lung, And Blood Institute1992–1996
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
